NCT03401788 · Interventional trial
A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)
Overall registry status Active not recruiting
Phase 2
Conditions VHL - Von Hippel-Lindau Syndrome, VHL Gene Inactivation, VHL Gene Mutation, VHL Syndrome, VHL-Associated Clear Cell Renal Cell Carcinoma, VHL-Associated Renal Cell Carcinoma
Delaware Valley sites
- University of Pennsylvania Medical Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory